Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xeris Pharmaceuticals Inc
(NQ:
XERS
)
2.840
+0.140 (+5.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xeris Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
December 30, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
December 27, 2021
Biotech stocks remain poised to eke out modest gains for 2021 after the stellar gains of the previous year. COVID-19 drug and vaccine developers experienced volatility throughout...
Via
Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...
Via
Benzinga
Xeris Biopharma Announces the Availability of Ogluo® in the UK Through Its Commercialization Partner, Tetris Pharma
December 16, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:
Via
Benzinga
41 Stocks Moving In Monday's Mid-Day Session
November 15, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...
Via
Benzinga
70 Biggest Movers From Yesterday
November 16, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...
Via
Benzinga
4 Penny Stocks Insiders Are Buying
November 15, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 15, 2021
Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!
Via
InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
November 15, 2021
Gainers Creative Realities, Inc. (NASDAQ: CREX) rose 132.9% to $3.40 in pre-market trading as the company reported a merger with Reflect Systems on Friday. Bit Brother Limited (...
Via
Benzinga
Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
November 10, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
Xeris Biopharma to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 10, 2021
November 02, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Why Xeris Pharmaceuticals Is Soaring 7% Higher Today
October 29, 2021
The biopharma is starting to put together a string of good news advances.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
October 25, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 25, 2021
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The company's market cap stands at $38.1 million....
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
October 29, 2021
Upgrades For Preferred Bank (NASDAQ:
Via
Benzinga
Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
October 25, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
45 Biggest Movers From Yesterday
October 08, 2021
Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial...
Via
Benzinga
Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma
October 05, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 01, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
Xeris Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 17, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 14, 2021
Gainers Xeris Pharmaceuticals (NASDAQ:XERS
Via
Benzinga
Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma
September 14, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 08, 2021
Gainers Cardiff Oncology (NASDAQ:
Via
Benzinga
Xeris Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
Xeris Pharmaceuticals Completes Enrollment of Its Phase 1 Study of Levothyroxine (XP-8121)
September 01, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.